We’ve recently updated our valuation analysis.

Huize Holding Valuation

Is HUIZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HUIZ?

Other financial metrics that can be useful for relative valuation.

HUIZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.2x
Enterprise Value/EBITDA-20.9x
PEG Ration/a

Price to Book Ratio vs Peers

How does HUIZ's PB Ratio compare to its peers?

The above table shows the PB ratio for HUIZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average0.6x
CUII China United Insurance Service
1.4xn/aUS$56.6m
SLQT SelectQuote
0.3x73.2%US$115.3m
EHTH eHealth
0.1x26.5%US$89.7m
RELI Reliance Global Group
0.4xn/aUS$11.5m
HUIZ Huize Holding
0.9x123.9%US$43.4m

Price-To-Book vs Peers: HUIZ is expensive based on its Price-To-Book Ratio (0.9x) compared to the peer average (0.6x).


Price to Earnings Ratio vs Industry

How does HUIZ's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.1%
n/an/an/a

Price-To-Book vs Industry: HUIZ is good value based on its Price-To-Book Ratio (0.9x) compared to the US Insurance industry average (1.2x)


Price to Book Ratio vs Fair Ratio

What is HUIZ's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HUIZ PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.9x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate HUIZ's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of HUIZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate HUIZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate HUIZ's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HUIZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$0.84
US$1.77
+110.8%
51.9%US$3.05US$1.00n/a3
Nov ’23US$0.51
US$1.82
+257.2%
47.0%US$3.03US$1.20n/a3
Oct ’23US$0.85
US$1.82
+115.1%
47.0%US$3.03US$1.20n/a3
Sep ’23US$0.90
US$2.21
+146.9%
32.3%US$3.19US$1.53n/a3
Aug ’23US$1.11
US$2.21
+100.0%
32.3%US$3.19US$1.53n/a3
Jul ’23US$1.29
US$2.17
+67.9%
29.5%US$3.04US$1.53n/a3
Jun ’23US$0.98
US$2.52
+156.8%
20.0%US$3.20US$1.99n/a3
May ’23US$1.03
US$2.52
+144.3%
20.0%US$3.20US$1.99n/a3
Apr ’23US$1.36
US$2.52
+85.0%
20.0%US$3.20US$1.99n/a3
Mar ’23US$1.32
US$4.93
+273.4%
72.7%US$10.00US$2.36n/a3
Feb ’23US$1.25
US$4.94
+294.8%
73.4%US$10.06US$2.34n/a3
Jan ’23US$1.43
US$4.94
+245.1%
73.4%US$10.06US$2.34n/a3
Dec ’22US$1.48
US$5.54
+274.6%
59.0%US$10.06US$2.40n/a3
Nov ’22US$2.02
US$6.26
+210.0%
42.3%US$10.00US$4.15US$0.513
Oct ’22US$2.23
US$6.24
+180.0%
42.8%US$10.01US$4.12US$0.853
Sep ’22US$2.83
US$8.86
+213.1%
9.7%US$10.00US$7.92US$0.903
Aug ’22US$3.65
US$8.86
+142.8%
9.7%US$10.00US$7.92US$1.113
Jul ’22US$5.89
US$8.86
+50.5%
9.7%US$10.00US$7.92US$1.293
Jun ’22US$6.40
US$9.01
+40.9%
10.1%US$10.24US$8.05US$0.983
May ’22US$6.90
US$10.00
+44.9%
0%US$10.00US$10.00US$1.031
Apr ’22US$8.99
US$10.00
+11.2%
0%US$10.00US$10.00US$1.361
Mar ’22US$9.09
US$10.00
+10.0%
0%US$10.00US$10.00US$1.321
Feb ’22US$6.46
US$10.00
+54.8%
0%US$10.00US$10.00US$1.251
Jan ’22US$7.00
US$10.60
+51.4%
0%US$10.60US$10.60US$1.431
Dec ’21US$7.46
US$10.60
+42.1%
0%US$10.60US$10.60US$1.481
Nov ’21US$7.00
US$10.60
+51.4%
0%US$10.60US$10.60US$2.021

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies